7.5(top 3%)
Impact Factor
8.2(top 3%)
extended IF
235(top 1%)
H-Index
10.1K
authors
14.6K
papers
550K
citations
11.2K
citing journals
176.9K
citing authors

Most Cited Articles of European Journal of Cancer

TitleYearCitations
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)200916.1K
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 201220133.8K
Radiomics: extracting more information from medical images using advanced feature analysis20122.3K
A survey of telomerase activity in human cancer19972.2K
Estimates of cancer incidence and mortality in Europe in 200820101.7K
EGFR and cancer prognosis20011.5K
Cancer burden in the year 2000. The global picture20011.4K
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group19991.3K
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation20011.3K
Immune-related adverse events with immune checkpoint blockade: a comprehensive review20161.2K
Curcumin: the story so far20051.2K
The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities20011.1K
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress19941.1K
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 201820181.1K
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy20061.1K
Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue19981K
Phase III trial of Anastrozole (AN) vs Tamoxifen (TAM) in Postmenopausal (PM) Patients (PTS) with hormone-dependent Advanced Breast Cancer (ABC)2001933
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure2005848
Correlation of Immunohistochemistry (IHC) and gene microarray analysis of breast biopsies from a preoperative endocrine therapy trial2001820
Etoposide: four decades of development of a topoisomerase II inhibitor1998728
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours2011727
The role of IL-6 and STAT3 in inflammation and cancer2005714
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours2006701
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group2010665
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary2009643